REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 202 filers reported holding REATA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.43 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $12,565,000 | -72.4% | 500,000 | -66.7% | 0.38% | -80.5% |
Q2 2022 | $45,585,000 | -7.2% | 1,500,000 | 0.0% | 1.98% | +11.2% |
Q1 2022 | $49,140,000 | -28.7% | 1,500,000 | +119.0% | 1.78% | -16.2% |
Q3 2021 | $68,918,000 | +4.7% | 685,000 | +47.3% | 2.12% | -4.3% |
Q2 2021 | $65,811,000 | +65.0% | 465,000 | +16.2% | 2.22% | +62.1% |
Q1 2021 | $39,880,000 | – | 400,000 | – | 1.37% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CPMG Inc | 2,896,901 | $291,457,000 | 32.14% |
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 46,646 | $4,693,000 | 5.31% |
Ikarian Capital, LLC | 471,400 | $47,423,000 | 3.34% |
Duquesne Family Office | 695,033 | $69,927,000 | 2.27% |
Camber Capital Management LP | 685,000 | $68,918,000 | 2.12% |
LBJ Family Wealth Advisors, Ltd. | 30,359 | $3,054,000 | 1.82% |
MADDEN SECURITIES Corp | 33,127 | $3,333,000 | 1.80% |
Biondo Investment Advisors, LLC | 104,120 | $10,475,000 | 1.80% |
Tolleson Wealth Management, Inc. | 60,750 | $6,112,000 | 1.73% |
Keel Point, LLC | 97,074 | $9,767,000 | 1.26% |